>PB439070.1 JP 2020508652-A/22675: METHODS FOR CELL-TYPE SPECIFIC PROFILING TO IDENTIFY DRUG TARGETS
AGAGTTATAGGGCCCCGCGTTAAGTCCATGAGCTTCCGTGAGGGTACTCTGCCGGTTTTGCTGCGGAAGT
CACCTCGTGGCGTAGGGGAGAGGTAACACCGAGAAGAGGCAGCGGCGGTGGCGCCAAGACGATTGGTGCC
AAACAGGGCAGAACGCAACTCAGCTCTGGGTTTGTGAATAGCACAATGGAAGAAGCTGGACTTTGTGGGT
TAAGAGAGAAAGCAGATATGTTGTGTAACTCTGAATCACATGATATTCTTCAACATCAAGACTCAAATTG
CAGTGCCACAAGTAATAAACATTTATTGGAAGATGAAGAAGGCCGTGACTTTATAACAAAGAACAGGAGT
TGGGTGAGCCCAGTGCACTGCACACAAGAGTCAAGAAGGGAGCTTCCTGAGCAAGAAGTAGCCCCTCCGT
CTGGTCAGCAAGCTTTACAATGCAACAGGAACAAAGAAAAAGTCTTAGAGAGACAAGGTCTTTCCCTGTC
ACCCAGGCTGGAGCGCGGTGGTACATTCATGGGTCATGGCAGCCTTAAACTCCCTGAGCTCGTGATCCTG
TCTCTTCAGACTCTAGAGTAGCTGGGGCTACAGGCGTACACCACCACACATGGCTAATTTTTTATTTTTC
TTTTGTTGTAGAGATGGGCTGTCATTCTCTTGCCCAGGCTGGTCTTGGTATACTGTCCTGTAGCAGTATA
TTTTGGCTACCTGTACTGGCATTGGCTTTTCCAAGTGTCAAGATTACAGAAGTTTTATTATTGATGCAAG
CCCTAAACACTCTTTCGACTCCAGAGGAGAAGCTGGCAGCTCTCTGTAAGAAATATGCTGATCTTGGAAA
TTCACCTCTTCTATAGAAGAGTTTGTTTTGAACTATACGATTTGAAACAAAATTCTTTTTTTGGAGACTA
TGGAAACATTCTCAACAGGGAAACCCTACTAGACTTTGTAAAGCAAATAATGGAAAAGATACAGAACTTT
TTGAAGAATCATGGGAAATT

